CDEK by Data4ThePeople

Sign in Sign up

← All organizations

DermBiont, Inc.

For profitWebsite ↗

Also known as: DermBiont, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 27, 2024

Timeline

2010s

Jan 1, 2017
DermBiont, Inc.— Founded

Drugs by trial phase (7 distinct, 13 trials)

Phase 2 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (15)

NCT06454747Lead sponsorPhase 2Jun 27, 2024
NCT06409195Lead sponsorPhase 2Mar 25, 2024
NCT06099080Lead sponsorPhase 2Nov 7, 2023
NCT06108024Lead sponsorPhase 2Nov 6, 2023
NCT05491603Study directorPhase 2Oct 31, 2022
NCT05491603Lead sponsorPhase 2Oct 31, 2022
NCT05493488Lead sponsorPhase 2Sep 8, 2022
NCT05493488Study directorPhase 2Sep 8, 2022
NCT05511948Lead sponsorPhase 2Aug 18, 2022
NCT05136144Lead sponsorPhase 2Oct 19, 2021
NCT05253755Lead sponsorPhase 2Oct 6, 2021
NCT04937920Lead sponsorPhase 2Mar 16, 2021
NCT04315051Lead sponsorPhase 2Sep 12, 2019
NCT04192513Lead sponsorPhase 2May 20, 2019
NCT04152226Lead sponsorPhase 2Feb 19, 2019

Details

Founded: Boston, MA, US Jan 1, 2017
Last known activity: Jun 27, 2024